Docusate sodium 50 MG Oral Capsule [Colace] — RxCUI 1247761
RxNorm drug concept · Semantic branded drug
RxCUI 1247761
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1247761
Official nameDocusate sodium 50 MG Oral Capsule [Colace]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asColace 50 MG Oral Capsule; DOSS Sodium 50 MG Oral Capsule [Colace]
FDA products mapped1
Package NDCs mapped4
Reported Medicaid activity (SDUD)5,402 prescriptions · 24 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Docusate sodium 50 MG Oral Capsule [Colace] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Docusate sodium 50 MG Oral Capsule [Colace]
RxCUI 1247761 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Docusate
82003IN -
Docusate sodium
71722PIN
-
Docusate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Colace
82000BN
-
Colace
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Docusate Oral Capsule
371943SCDF -
Docusate sodium Oral Capsule
2646968SCDFP -
Docusate Oral Product
1160200SCDG -
Docusate Pill
1160202SCDG -
Docusate sodium Oral Product
2661151SCDGP -
Docusate sodium Pill
2663394SCDGP -
Docusate Oral Capsule [Colace]
366325SBDF -
Docusate sodium Oral Capsule [Colace]
2657462SBDFP - +5 more in this family
-
Docusate Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Docusate sodium 50 MG Oral Capsule
1247759SCD -
Docusate sodium 50 MG
836262SCDC -
Docusate sodium 50 MG [Colace]
1247760SBDC
-
Docusate sodium 50 MG Oral Capsule
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Docusate sodium 50 MG Oral Capsule
SCD · 1247759 -
Docusate sodium 50 MG
SCDC · 836262 -
Docusate Oral Capsule
SCDF · 371943 -
Docusate sodium Oral Capsule
SCDFP · 2646968 -
Docusate Oral Product
SCDG · 1160200 -
Docusate Pill
SCDG · 1160202 -
Docusate sodium Oral Product
SCDGP · 2661151 -
Docusate sodium Pill
SCDGP · 2663394
Brand-Name Concepts
-
Docusate sodium 50 MG [Colace]
SBDC · 1247760 -
Docusate Oral Capsule [Colace]
SBDF · 366325 -
Docusate sodium Oral Capsule [Colace]
SBDFP · 2657462 -
Colace Oral Product
SBDG · 1176451 -
Colace Pill
SBDG · 1176452 -
Colace
BN · 82000
📦 FDA Products & Package NDCs
1 product · 4 package NDCs
4 package NDCs map to RxCUI 1247761 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 67618-0111-10 | 1 BOTTLE in 1 CARTON (67618-111-10) / 100 CAPSULE, LIQUID F... | Colace | Atlantis Consumer Healthcare, Inc. | 2025-12-01 |
| 67618-0111-28 | 1 BOTTLE in 1 CARTON (67618-111-28) / 28 CAPSULE, LIQUID FI... | Colace | Atlantis Consumer Healthcare, Inc. | 1900-01-07 |
| 67618-0111-42 | 1 BOTTLE in 1 CARTON (67618-111-42) / 42 CAPSULE, LIQUID FI... | Colace | Atlantis Consumer Healthcare, Inc. | 2024-02-01 |
| 67618-0111-60 | 1 BOTTLE in 1 CARTON (67618-111-60) / 60 CAPSULE, LIQUID FI... | Colace | Atlantis Consumer Healthcare, Inc. | 2024-04-01 |
Observed labelers:
Atlantis Consumer Healthcare, Inc. (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.2563
Range $0.2563–$0.2563
· middle 50% $0.2563–$0.2563
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.